SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
Zexuan Liu(Central South University), Ratna K. Vadlamudi(The University of Texas at San Antonio Health Science Center)
Cited by 30
Related Papers
Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein
|Journal of Biological Chemistry|2003|90
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
|Breast Cancer Research|2012|82
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
|Scientific Reports|2016|71
PELP1 oncogenic functions involve CARM1 regulation
|Carcinogenesis|2013|70
Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response
|Cell Death and Differentiation|2014|33